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Summary
An important step for cholinergic transmission in-
volves the vesicular storage of acetylcholine (ACh), a
processmediated by the vesicular acetylcholine trans-
porter (VAChT). In order to understand the physiolog-
ical roles of the VAChT, we developed a genetically
altered strain of mice with reduced expression of this
transporter. Heterozygous and homozygous VAChT
knockdown mice have a 45% and 65% decrease in
VAChT protein expression, respectively. VAChT defi-
ciency alters synaptic vesicle filling and affects ACh
release. Whereas VAChT homozygous mutant mice
demonstrate major neuromuscular deficits, VAChT
heterozygous mice appear normal in that respect and
could be used for analysis of central cholinergic func-
tion. Behavioral analyses revealed that aversive learn-
ing and memory are not altered in mutant mice; how-
ever, performance in cognitive tasks involving object
*Correspondence: m.caron@cellbio.duke.edu (M.G.C.); mprado@
icb.ufmg.br (M.A.M.P.)
8 Present address: Department of Pharmacology, College of Medi-
cine, Dankook University, San-29, Anseo-dong, Cheonan, Choong-
nam 330-714, Korea.and social recognition is severely impaired. These
observations suggest a critical role of VAChT in the
regulation of ACh release and physiological functions
in the peripheral and central nervous system.
Introduction
Acetylcholine (ACh) plays a crucial role in controlling a
number of physiological processes in both the periph-
eral and central nervous system. Synthesis of ACh
requires efficient uptake of choline by the high-affinity
choline transporter and choline acetylation by the en-
zyme choline acetyltransferase (ChAT) (Ribeiro et al.,
2006). Efficient release of ACh from nerve endings de-
pends on its storage in synaptic vesicles, a step reliant
on the activity of a vesicular acetylcholine transporter
(VAChT) (Parsons, 2000). VAChT is a twelve-transmem-
brane domain protein that uses the electrochemical gra-
dient generated by a V-type proton ATPase to accumu-
late ACh in synaptic vesicles. VAChT and the vesicular
monoamine transporters (VMATs) share a high degree
of homology in their transmembrane domains and be-
long to the SLC18 (or solute carrier) family of proton/
neurotransmitter antiporters (Erickson et al., 1994; Re-
imer et al., 1998; Roghani et al., 1994).
The ACh transporter is likely to provide stringent con-
trol of the amount of neurotransmitter stored and re-
leased by cholinergic nerve endings (Prado et al.,
2002). VAChT trafficking to secretory vesicles appears
to be the target of cellular regulation, and phosphoryla-
tion by protein kinase C (PKC) influences delivery of
VAChT to synaptic-like microvesicles in PC12 cells
(Cho et al., 2000; Krantz et al., 2000). However, the con-
sequences of reduced targeting of VAChT to synaptic
vesicles for ACh output in vivo are unknown.
Deficits in central or peripheral ACh neurotransmis-
sion have been described in several human disorders,
including Alzheimer’s disease (AD), in which certain be-
havioral and cognitive abnormalities have been related
to brain cholinergic dysfunction (Bartus et al., 1982;
Mesulam, 2004). However, the relationship between
cholinergic decline and specific behavioral deficits is
still not completely appreciated. Basal forebrain lesions
in rats, with immunotoxins targeting the p75 neurotro-
phin receptor, indicate that ACh plays an essential role
in attention (Sarter and Parikh, 2005), whereas it seems
to participate, but it is not essential, in hippocampal-
dependent spatial learning and memory (Parent and
Baxter, 2004).
To investigate the consequences of reduced expres-
sion of VAChT on ACh neurotransmission and function,
we genetically modified mice to produce a knockdown
(KD) of VAChT gene expression. We observed a strong
relationship between the levels of VAChT expression
and ACh release in both the peripheral and central ner-
vous systems. A marked reduction of VAChT expression
was necessary to affect neurotransmission at the neuro-
muscular junction, while even modest deficiency was
sufficient to interfere with brain ACh release and affect
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602Figure 1. Schematic Drawing of the Choliner-
gic Gene Locus and Generation of VAChT-
Deficient Mice
(A) Boxes represent the different exons of
ChAT or VAChT. The position of the initiation
codon (ATG) for VAChT and ChAT and the
stop codon (stop) of VAChT are indicated.
Potential transcription initiation sites are
indicated for VAChT (filled arrowheads) and
ChAT (open arrowheads). Note that the
VAChT gene is within the first intron of ChAT.
(B) Schematic representation of the VAChT
gene locus, the targeting construct, and the
recombinant DNA. P1, P2, and P3 indicate
position of PCR primers used for genotyping.
Open white circles indicate loxP sites.
(C) PCR analysis of wild-type (lane 1), hetero-
zygous VAChT KD mice (lane 2), and homozy-
gous VAChT KD mice (lane 3). Lane 4 is a neg-
ative control without DNA.
(D) Southern analysis of wild-type (lanes 1),
VAChT KDHET (lane 2), and VAChT KDHOM
mice (lane 3).
(E) Northern blot analysis of VAChT, ChAT,
and CHT1 in spinal cord for wild-type (lane
1), VAChT KDHET (lane 2), and VAChT KDHOM
mice (lane 3). Kidney mRNA was isolated,
and Northern analysis detected no signal for
VAChT, ChAT, and CHT1 transcripts.
(F) Quantification of cholinergic transcripts.
Blots were scanned and densitometric analy-
sis was performed using the actin signal to
normalize mRNA levels. Data are presented
as a percentage of wild-type levels. (*) indi-
cates statistical significant differences as
described in the text.behavior. Moreover, these investigations revealed a role
for cholinergic tone in processing complex cues, which
manifested as cognitive deficits in mutant mice for ob-
ject and social memory.
Results
Molecular Analysis
To investigate the physiological consequences of al-
tered expression of VAChT as related to vesicle filling
and ACh release, we generated a mouse line with de-
creased expression rather than complete deletion, of
this transporter, so we could investigate the conse-
quences of reduced cholinergic tone in vivo (Figures
1A and 1B for wild-type and mutant alleles, respec-
tively). PCR and Southern analyses confirmed homolo-
gous recombination and targeting of the 50 untranslated
region of the VAChT gene in genetically altered mice
(Figures 1C and 1D). Mutant mice were born at the
expected Mendelian frequency, survived, and exhibited
no gross abnormalities.
Northern analysis of spinal cord indicated that the
major mRNA species for VAChT (V1, 2.6 kb) was signifi-
cantly reduced by 40% and 62% in VAChT KDHET and
KDHOM mice, respectively [F(2,11) = 11.09, p < 0.005,
one-way ANOVA, Figures 1E and 1F]. Surprisingly, a
second VAChT species of 3.0 kb, which was especiallyapparent in spinal cord, was significantly increased in
VAChT KD mice, suggesting that compensatory tran-
scriptional mechanisms operate in response to changes
in VAChT expression. The changes in mRNA were spe-
cific for VAChT transcripts, as we detected no significant
changes in mRNA levels for ChAT [F(2,3) = 0.0311, p =
0.970] and CHT1 [F(2,12) = 0.0921, p = 0.9127] in mutant
mice (Figures 1E and 1F). These results agree with the
lack of significant alterations found in ChAT activity
and high-affinity choline transport in mutant mice (see
Figure S1 in the Supplemental Data). Control experi-
ments using kidney mRNA demonstrated the specificity
of the probes (Figure 1E).
We investigated the consequences of altered expres-
sion of VAChT mRNA in VAChT KD mice by probing
protein expression by immunoblot analysis. These ex-
periments show a reduction of close to 50% in immuno-
reactivity for VAChT in the hippocampus [two-way
ANOVA followed by Bonferroni post hoc, F(2,23) = 70.95,
p < 0.001, Figures 2D and 2E] and in other brain regions
(Figures 2A–2E) of VAChT KDHET mice compared to
wild-type control mice. In contrast, levels of other pre-
synaptic proteins were not altered (Figures 2A–2E). Re-
sults were similar in all brain regions and in spinal cord
(Figure 2E, overall decrease in all tissues was 56% 6
4% of the wild-type levels, n = 20). These results indicate
a significant reduction in VAChT protein in VAChT KDHET
Mouse Model of Cholinergic Dysfunction
603Figure 2. Gene Targeting Alters VAChT Pro-
tein Levels
Western blot analysis of VAChT, synaptophy-
sin, and syntaxin in the cortex (A), striatum
(B), spinal cord (C), and hippocampus (D) of
wild-type (lane 1), VAChT KDHET (lane 2),
and VAChT KDHOM mice (lane 3). (E) Quantifi-
cation of protein levels. Actin immunoreactiv-
ity was used to correct for protein loading be-
tween experiments. Data are presented as a
percentage of wild-type levels. (*) indicates
statistical significant difference (one-way An-
ova with Bonferroni post hoc [cortex, F(2,9) =
49.11, p < 0.001; striatum, F(2,6) = 27.24, p <
0.001; spinal cord, F(2,9) = 95.75, p < 0.001;
Hippocampus, F(2,23) = 70.95, p < 0.001]).mice. VAChT KDHOM mice showed further decrease in
VAChT protein levels (65% to 70%, Figures 2A–2E).
Thus, VAChT KDHOM mice present an even larger de-
crease in levels of transporter than VAChT KDHET mice,
but VAChT expression in homozygous mutant mice is
sufficient for survival.
Electrophysiological Analysis and Neuromuscular
Function
In order to evaluate the impact of reduced VAChT ex-
pression on quantal ACh release, we examined neuro-
muscular transmission. Miniature end-plate potentials
(MEPPs) were readily recorded at neuromuscular junc-
tions from either wild-type, VAChT KDHET, or VAChT
KDHOM mice. To compare quantal size we recorded at
least 100 MEPPs from each of five fibers from five to
seven animals of each genotype. MEPPs from mutant
mice were smaller than those from wild-type, as can
be seen in histograms of MEPP amplitudes (Figure 3A).
To avoid possible histogram binning artifacts, we also
analyzed the cumulative distribution of MEPP ampli-
tudes, which showed a similar shift to smaller MEPPs
in mutant animals (Figure 3B, p< 0.001 for VAChT
KDHOM, p < 0.05 for VAChT KDHET, Kolmogorov-Smirnoff
test). Further statistical analysis using ANOVA on aver-
ages of either the peak amplitude or the area of MEPPs
confirmed the statistical significance of the differences
in quantal sizes between wild-type and VAChT KDHOM
animals [F(1,71) = 8.7, p < 0.005]. Therefore, mutant
mice appear to pack less ACh in each synaptic vesicle.
In addition to quantal size, MEPP frequency was also
strongly reduced in VAChT KDHOM animals, as shown in
Figure 3C. The frequency of MEPPs was 0.696 0.08 s21
in wild-type animals (40 synapses from seven animals),
0.79 6 0.18 s21 in VAChT KDHET animals (30 synapses
from five animals), and 0.376 0.05 s21 in VAChT KDHOM
mice (41 synapses from seven animals). The difference
in MEPP frequency between wild-type and VAChT
KDHOM mice was statistically significant [two-way
ANOVA followed by Bonferroni post hoc, F(1,18) =
10.3, p < 0.005].
The observed decrease in MEPP frequency at junc-
tions from KDHOM mice could be due to a reduction in
the number of synaptic vesicles available for release, a
reduction in vesicle release probability, or a population
of synaptic vesicles whose ACh load is below our detec-tion limit. To investigate these possibilities, we measured
evoked end-plate potentials (EPPs) during 100 Hz trains
after cutting the muscle fibers to avoid contraction. Un-
der these conditions, EPP amplitudes during a train rap-
idly fell from their initial level to a depressed steady state
over the course of the first ten stimuli (Figure 3D). Overall,
initial depression of normalized EPPs was similar in re-
cordings from wild-type and KDHOM animals, suggesting
similar release probabilities. Quantal content of each
EPP during a train was calculated based on measured
MEPP amplitudes, thus permitting an estimate of the
size of the readily releasable pool of vesicles as de-
scribed (Elmqvist and Quastel, 1965). This analysis con-
sidered only the first eight responses during a train for
which the relationship between EPP versus cumulative
EPP was linear. With this method, the readily releasable
pool was similar for both genotypes and estimated at
439 6 73 vesicles in synapses from wild-type animals
and 550 6 59 vesicles in VAChT KDHOM synapses (p =
0.52, two-tailed Student’s t test). In contrast, the extent
of steady-state depression of EPPs was significantly
greater in VAChT KDHOM animals compared with wild-
type [one-way ANOVA, F(1,70) = 197, p < 0.001].
Assuming constant quantal size, the increase in de-
pression uncovered in the above experiments would
suggest a defect in mobilizing or recycling of ACh-filled
vesicles; however, the assumption of constant quantal
size during the stimulus train may not be valid for mutant
animals. Therefore, we attempted to directly test
whether synaptic vesicle exo- and endocytosis would
be altered in mutant mice. For this we performed exper-
iments with the vital dye FM1-43 (Richards et al., 2000),
which provides the opportunity for optical detection of
both exocytosis and endocytosis of synaptic vesicles.
Labeling of nerve terminals in junctions from both wild-
type and KDHOM animals in response to 60 mM KCl
(10 min) was indistinguishable, and no differences were
detected upon quantification of fluorescent spots (Fig-
ure 3E), suggesting that endocytosis occurs to the same
extent in both genoytypes. Destaining of fluorescent
spots in response to 60 mM KCl was calcium dependent
(not shown), and was not different between wild-type
and KDHOM animals (Figure 3F), indicating that synaptic
vesicle exocytosis is not changed in VAChT KDHOM
mice. Thus, taken together, our observations would sug-
gest that the alterations in MEPP frequency and EPP
Neuron
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sequence of decreased transport of ACh by synaptic
vesicles.
To evaluate whether the alterations detected in neuro-
muscular transmission may affect neuromuscular func-
tion, we tested the performance of wild-type and mutant
mice in motor tasks (Figure 4). In the wire-hang test
(Figure 4A), wild-type and VAChT KDHET mice show no
differences in performance; however, VAChT KDHOM
mice were significantly impaired [F(2,37) = 28.77, p <
0.001]. This altered performance of VAChT KDHOM ani-
mals is likely the result of altered neuromuscular force,
since these mutants were also severely impaired in a
Figure 3. Neuromuscular Transmission in VAChT KDHET and VAChT
KDHOM Mice
(A) Normalized histogram of MEPP amplitudes for wild-type (black
line, 3302 MEPPs), VAChT KDHET (blue line, 4319 MEPPs), and
VAChT KDHOM (red line, 3690 MEPPs) mice. Data are from five syn-
apses from five to seven animals for each genotype.
(B) Quantal size of the three genotypes quantified by plotting the cu-
mulative frequency of MEPP amplitudes. Black line, wild-type; blue
line, VAChT KDHET; red line, VAChT KDHOM.
(C) Frequency of MEPPs at synapses from the three genotypes. (*)
indicates statistically significant difference from control wild-type
mice (two-way ANOVA followed by Bonferroni post hoc; F(1,18) =
10.3, p < 0.005).
(D) Normalized EPP amplitude (to the first stimulus) for wild-type
(black line) and VAChT KDHOM (red line) mice in response to a train
of 100 Hz (0.5 s). Data are from ten synapses from three wild-type
animals and 16 synapses from three KDHOM animals.
(E) Nerve terminals from wild-type and VAChT KDHOM mice were la-
beled with FM1-43 and show similar patterns of staining. Data are
mean 6 SEM of 109 fluorescent spots from 21 nerve terminals of
wild-type mice and 111 fluorescent spots from 26 nerve terminals
from VAChT KDHOM. Scale bar, 10 mm.
(F) Destaining of FM1-43-labeled nerve endings from wild-type
(black line) and VAChT KDHOM (red line). Data are mean 6 SEM of
26 fluorescent spots (wild-type mice) and 21 fluorescent spots
(VAChT KDHOM) from four mice per genotype.grip strength test when compared with wild-type mice
[Figure 4B, F(3,48) = 9.52, p < 0.001]. By comparison,
VAChT KDHET mice present no deficit in neuromuscular
function as assessed in this test. Importantly, reduced
grip strength in VAChT KDHOM mice was improved by
prior injection of one of three cholinesterase inhibitors:
pyridostigmine (i.p., 1 mg/kg), galantamine (s.c., 1 mg/kg)
or physostigmine (i.p., 0.3 mg/kg) [Figure 4B, F(3,47) =
8.323, p < 0.05]. No change in grip force was observed
in wild-type mice treated similarly with any of the above
cholinesterase inhibitors at the doses used (not shown).
Since pyridostigmine is charged and should not cross
the blood-brain barrier, its efficacy in improving grip
force observed in homozygous mutant mice directly
implicates peripheral cholinergic transmission in this
effect.
To further study neuromuscular output, we examined
performance of VAChT mice on the rotarod. This test de-
pends not only on the ability of mice to learn motor skills,
but also on their ability to maintain prolonged motor
function. Wild-type mice were able to learn this motor
task, and after five trials their performance was signifi-
cantly better than their performance during the first trial
[Figure 4C, repeated measures ANOVA, F(13,195) = 16.9,
p < 0.05]. The performance of VAChT KDHET mice im-
proved significantly only after 12 trials on the rotarod [re-
peated measures ANOVA, F(13,117) = 4.63, p < 0.05]. In
contrast, VAChT KDHOM mice never learned this motor
task [Figure 4C, F(13,91) = 0.653] and their performance
was significantly worse than those of wild-type and
VAChT KDHET mice [F(2,434) = 60.16, p < 0.05 on trials
12, 13, and 14, two-way ANOVA followed by Bonferroni
post hoc tests].
The performance of VAChT KDHOM mice may indicate
either motor learning deficits on the rotarod or that mu-
tant mice are incapable of sustained physical activity. To
evaluate the latter possibility, we used a treadmill to
evaluate the performance of wild-type, VAChT KDHET,
and VAChT KDHOM mice in exhaustive physical activity.
Figure 4D shows that VAChT KDHOM mice were not able
to maintain long periods of physical activity and per-
formed poorly compared with wild-type or VAChT KDHET
mice [one-way ANOVA followed by Bonferroni post hoc,
F(2,28) = 22.09, p < 0.001]. Indeed, VAChT KDHOM mice
could run for no more than 5 min on the treadmill,
whereas wild-type or VAChT KDHET mice could usually
run for longer than 60 min. These results indicate that
VAChT KDHOM mice are unable to perform on the rotarod
due to their decreased capacity to maintain physical
activity. They also indicate that VAChT KDHET mice ap-
pear as physically fit as wild-type control mice under
the conditions tested.
Neurochemical Analysis
VAChT KDHOM mice display significant neuromuscular
deficiency, which may confound the outcomes of com-
plex behavioral tests aimed at assessing consequences
of central ACh deficiency. In contrast, VAChT KDHET mice
have essentially normal neuromuscular transmission,
thereby indicating their potential usefulness as test sub-
jects for investigating the behavioral consequences of
mild reductions of central cholinergic function.
To investigate the functional consequences of reduced
VAChT expression, we first used brain microdialysis to
Mouse Model of Cholinergic Dysfunction
605Figure 4. Neuromuscular Function of VAChT
KDHET and VAChT KDHOM Mice
(A) Time spent hanging upside-down from a
cage by wild-type, VAChT KDHET, and VAChT
KDHOM mice. *p < 0.05 from wild-type controls
(one-way ANOVA followed by Bonferroni post
hoc; F[2,37] = 28.77, p < 0.05, n = 20 wild-type,
n = 12 VAChT KDHET, and n = 8 VAChT KDHOM).
(B) Grip force measured for wild-type, VAChT
KDHET, VAChT KDHOM, and VAChT KDHOM
mice treated with pyridostigmine (i.p., 1 mg/kg),
galantamine (s.c., 1 mg/kg) and physostig-
mine (i.p., 0.3 mg/kg) 30 min prior to the test.
(*) indicates statistical difference when com-
pared with VAChT KDHOM mice without cho-
linesterase treatment.
(C) Performance of wild-type (clear squares),
VAChT KDHET (gray squares), and VAChT
KDHOM mice (black squares) on the rotarod
task. (*) indicates statistically significant dif-
ferences compared with the first trial for
each genotype (repeated measures ANOVA,
p < 0.05). (#) indicates statistically different
performance when compared with wild-type
mice [two-way ANOVA shows an effect of
genotype; F(2,434) = 60.16, p < 0.05].
(D) Exercise capacity of wild-type, VAChT
KDHET, and VAChT KDHOM mice. Mice were
trained on the treadmill with a protocol that
evaluated physical capacity (see Experimen-
tal Procedures). After training mice, were
tested for performance, and the work (in J)
done was calculated.establish extracellular levels of ACh in freely moving
VAChT KDHET mice. Because all brain regions examined
appeared to show similar reductions in VAChT expres-
sion, we chose to determine extracellular ACh levels in
frontal cortex and striatum. Frontal cortex was selected
because this brain region receives innervation from nu-
cleus basalis and substantia innominata, areas known
to be affected in Alzheimer’s disease. Striatum was cho-
sen because it contains the largest concentration of cho-
linergic nerve endings and is therefore particularly suit-
able to evaluate possible decreases in extracellular
ACh. The quantitative ‘‘low perfusion rate’’ microdialysis
approach, which allows precise determination of a given
extracellular neurotransmitter (Gainetdinov et al., 2003),
revealed that levels of extracellular ACh were depressed
by more than 35% in frontal cortex [t(1,19) = 2.642, p <
0.016] and by approximately 31% in striatum [t(1,18) =
2.560, p < 0.020] of VAChT KDHET mice (Figure 5A).
Next, by using the conventional microdialysis approach,
we examined the dynamic responses to KCl-stimulated
ACh release in the striatum. After establishing basal ex-
tracellular ACh levels, artificial cerebrospinal fluid (CSF)
containing 60 mM [K+] was perfused through the micro-
dialysis probe over the next 40 min, and the probe was
returned to normal artificial CSF for the remaining
40 min of the experiment (Figure 5B). A repeated mea-
sures ANOVA revealed a significant main effect of time
[F(5,60) = 31.541, p < 0.001] and a significant time by
genotype interaction [F(5,60) = 7.502, p < 0.001]. Bonfer-
roni-corrected pairwise comparisons showed genotype
effects at 40 (p < 0.044), 60 (p < 0.023), and 80 min (p <
0.026). Hence, both genotypes responded to KCl depo-
larization; however, stimulated release in KDHET striatum
was reduced relative to that of the wild-type controls.Since VAChT is responsible for sequestering ACh into
secretory vesicles, we evaluated the effects of de-
creased VAChT expression on total ACh levels in brain
tissue. When tissue concentrations of ACh were mea-
sured by high-performance liquid chromatography
(HPLC) with eletrochemical detection (HPLC-EC), levels
in frontal cortex and striatum of VAChT KDHET mice were
significantly increased by approximately 49% [t(1,25) =
4.082, p < 0.001] and 30% [t(1,10) = 3.408, p < 0.007],
respectively, over that of the wild-type controls (Fig-
ure 5C). These data were replicated in a complementary
chemiluminescence assay in a separate group of mice
using both striatum and hippocampus (Figure 5D; p <
0.05). Moreover, VAChT KDHOM mice show an even
larger increase in ACh content in the brain, and this in-
crease was statistically different from that of VAChT
KDHET mice or wild-type mice (Figure S1C; p < 0.05).
This increase in ACh content for mutant mice cannot
be attributed to an increase in ChAT activity (Figure S1A),
high-affinity choline transporter activation (Figure S1D),
or increased levels of expression of ChAT (Figures S1B
and S1E) or CHT1 (Figure 1E). Whereas the mechanism
of such an increase in total tissue ACh content it is not
immediately apparent, it is important to emphasize
that the functional ‘‘releasable’’ ACh pool seems to be
decreased, as evidenced by in vivo microdialysis exper-
iments and quantal analysis at the neuromuscular junc-
tion. All together, these results demonstrate that a
reduction of approximately 50% in the levels of VAChT
expression in the brain results in a significant decrease
in the release of ACh in vivo, despite enhanced intracel-
lular content of neurotransmitter. These observations
suggest a complex relationship between the control of
storage and release of ACh in CNS neurons.
Neuron
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After documenting normal performance of VAChT KDHET
mice in tests of neuromuscular strength, despite re-
duced cholinergic tone in the brain, we proceeded to
evaluate performance of mutants in behavioral tasks
reflecting CNS cholinergic function. VAChT KDHET mice
were tested for performance in the step-down inhibitory
avoidance task, a task that depends upon hippocampal
and amygdala networks and may be sensitive to manip-
ulations in central cholinergic function (Izquierdo and
Medina, 1997). Both genotypes exhibited learning, as la-
tency to step-down from the platform increased from
10 to 15 s to approximately 80 to 100 s after training.
In parallel experiments, we determined in another cohort
of mice that the unconditioned stimulus was essential
for both genotypes to learn the task (data not shown).
VAChT KDHET performed as well as wild-type littermates
on this task on a short-term (1.5 hr after learning) and
long-term (24 hr after learning) memory test, suggesting
that this specific aspect of learning and memory is pre-
served in animals with a mild decrease in cholinergic
tone (Figure 6A).
A second test for memory, based on the ability to dis-
criminate novel objects, was used to evaluate the per-
formance of mutant mice. In the object recognition
task, mice explore two objects, and after a latency of
1.5 or 24 hr they are presented with one of the familiar
Figure 5. Neurochemical Alterations in VAChT KDHET Mice
(A) Extracellular ACh levels as determined by quantitative low perfu-
sion rate microdialysis in frontal cortex and striatum. n = 10 mice per
genotype per brain region.
(B) KCl-stimulated release of ACh in striatum of freely moving mice.
Following 40 min of baseline collection of ACh, 60 mM [K+] was
infused through the microdialysis probe for 40 min, and artificial
CSF was infused over the last 40 min of the experiment. n = 7 mice
per genotype. *p < 0.05 for wild-type controls.
(C) Tissue ACh contents in frontal cortex (FC) and striatum (ST) of
wild-type and KDHET mice measured by HPLC with electrochemical
detection. FC: n = 14 (wild-type), n = 13 (KDHET); ST: n = 6 mice per
genotype.
(D) Striatal (ST) and hippocampal (HIP) tissue ACh levels assayed by
chemiluminescent detection in wild-type (open bars) and VAChT
KDHET (gray bars) mice (n = 5). In all panes, data are mean 6 SEM.
*p < 0.05 for wild-type controls.objects and a nonfamiliar object. Initial exploration
time of two objects was identical for both genotypes, in-
dicating that they both show preference for novelty (data
not shown). However, whereas wild-type mice exhibited
a significant increase in the exploration of the unfamiliar
object, mutant mice performed poorly compared to
wild-type mice in their ability to remember the familiar
object both 1.5 and 24 hr after learning (Figure 6B, p <
0.05, Kruskal-Wallis analysis of variance and Mann-
Whitney U tests, n = 12–18). Thus, VAChT KDHET mice
appear to have a cognitive deficit that impacts behavior
in this test.
Recognition of a familiar conspecific is the basis of
several social interactions, including hierarchical social
relationship and mate choice (Winslow and Insel,
2004). There is evidence for the participation of nicotinic
and muscarinic central systems in social recognition in
rodents (Prediger et al., 2006; van Kampen et al., 2004;
Winslow and Camacho, 1995), and social recognition
deficits may relate to cholinergic decline in a mouse
model of AD (Ohno et al., 2004). We evaluated social
interactions of VAChT KDHET mice in a habituation-dis-
habituation paradigm using a mouse intruder (Choleris
et al., 2003). Wild-type control mice showed extensive
exploration of the intruder (e.g., sniffing) during first con-
tact. This response decreased with subsequent expo-
sure to the same juvenile [F(4,11) = 60.93, p < 0.01], indi-
cating that wild-type control mice readily habituated to
the conspecific (Figure 6C). Hence, after four exposures
to the same juvenile, wild-type mice explored the in-
truder for only one-third of the length of time of the initial
exploration. Upon changing to an unfamiliar mouse,
wild-type animals showed a renewed interest in investi-
gation, and explored the new mice as much as they ex-
plored the original intruder during the first contact (Fig-
ure 6C). These results indicate that lack of interest in
exploring the first intruder upon recurring exposure
was not attributable to lack of motivation, but appears
to be due to habituation, i.e., learning. Exploration of
the intruder mice by VAChT KDHET mice on the first con-
tact was slightly less than that observed for wild-type
animals (p < 0.05, two-way ANOVA with Bonferroni
post hoc). Upon subsequent exposures, VAChT KDHET
mice show statistically significant differences in explo-
ration of the intruder mice as compared with wild-type
mice (p < 0.001, two-way ANOVA with Bonferroni post
hoc). In sharp contrast to wild-type littermates, VAChT
KDHET mice failed to habituate to the juvenile intruder
in the subsequent exposures after the initial contact,
and only after the fourth contact was there a significant
difference in exploratory behavior compared with the
first encounter [F(4,10) = 5.293, Figure 6C)]. Introduction
of an unfamiliar mouse led VAChT KDHET mice to in-
crease their exploration, indicating that the decrease
in exploration during the fourth exposure for the first
intruder was not due to nonspecific effects such as
physical exhaustion or motivation.
One possible explanation for the inability of VAChT
KDHET mice to habituate to a conspecific is that mutant
mice have olfactory deficits. In a control experiment,
we evaluated olfactory responses in these mice. How-
ever, both wild-type and VAChT KDHET mice showed
similar abilities in finding a hidden food reward (data
not shown), suggesting that the differences observed
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KDHET Mice
(A) Step-down inhibitory avoidance task. Re-
tention test latency measured 90 min after
training (STM) and again at 24 hr (LTM). Ordi-
nates express median (interquartile range)
test session latency, in seconds. Open bars
represent the performance of wild-type mice
and shadowed bars represent that of VAChT
KDHET mice (n = 13–18 per group). *p < 0.05
compared with performance of mice during
training.
(B) Object recognition test. Results are shown
as median (interquartile ranges) recognition
indexes of short-term (STM) and long-term
(LTM) retention test trials. Clear bars repre-
sent data from wild-type mice and shadow
bars are the data from VAChT KDHET mice.
(#) indicates a significant difference from
wild-type; p < 0.05, n = 12–18. *p < 0.05 com-
pared with performance of mice during
training.
(C) Social memory of wild-type (open
squares) and KDHET (gray squares) mice was
measured as olfactory investigation during
each of four successive 5 min trials with an
intertrial interval of 15 min. A fifth dishabitua-
tion trial depicts the response of mice to the
presentation of a new intruder in a 5 min pair-
ing, 15 min after the fourth trial. *p < 0.05 com-
pared with performance on the first trial within
the genotype, and #p < 0.05 when compared
with wild-type control mice; n = 10–12.
(D) Olfactory function of wild-type and VAChT
KDHET mice. Mice were presented a straw-
berry essence for 1 min in 4 sequential trials with an intertrial interval of 10 min. On the 5th trial, vanilla essence was presented. *p < 0.05 from
the first trial within genotype. No between group differences were observed.
(E) Social preference of wild-type (open bar) and VAChT KDHET mice. Only the percentage of exploration for the social stimulus is shown.
(F) Social memory of wild-type (open bars, n = 14), VAChT KDHET (gray bars, n = 14), and VAChT KDHET mice treated with galantamine (s.c., 1 mg/kg)
30 min prior to the first exposure to an intruder (hatched bars, n = 8). The intruder is presented in each of two 5 min trials with an intertrial interval of
30 min. *p < 0.05 for the first trial within the genotype. Unless otherwise stated, data are mean 6 SEM.in social recognition do not relate to deficits in olfactory
function. In addition, wild-type and VAChT KDHET mice
habituated to a test odor similarly [wild-type, F(4,6) =
11.35, and VAChT KDHET mice, F(4,6) = 18.11, p < 0.05
by repeated measures ANOVA]. There were no differ-
ences between the two genotypes in olfactory habitua-
tion or in their ability to discriminate between two test
odors (Figure 6D).
A second possibility to explain the deficit in social ha-
bituation is that VAChT KDHET mice are more social than
wild-type mice, i.e., they prefer the company of intruder
mice more than wild-type mice do. This would be the
converse of the autistic-like behavior found in PTEN mu-
tant mice (Kwon et al., 2006). To specifically test this
possibility, we evaluated the choice of wild-type and
VAChT KDHET mice for a social stimulus (an adult mouse
in an acrylic cage that allowed minimum tactile explora-
tion but allowed olfactory exploration) against a nonso-
cial stimulus (an identical acrylic cage which was never
previously presented to the mice). This experiment
was done in specially designed boxes containing two
separate rooms, each of which the mice had to enter
to explore the social or nonsocial target, respectively
(Kwon et al., 2006). As expected from the previous ex-
periment, both genotypes had a stronger preference
for the social against the nonsocial stimuli (Figure 6F);however, VAChT KDHET mice expended significantly
less time with the social stimulus and consequently
more time with the nonsocial stimulus than wild-type
control mice did (p < 0.05, Student’s t test). Therefore,
increased social preference of VAChT KDHET mice can-
not explain the lack of habituation observed in the social
recognition test. If anything, the data indicate that
VAChT KDHET mice are less social than control mice.
The results above suggest that VAChT KDHET mice
have a deficit in social memory. This deficit could be a
consequence of decreased ACh release, or it could re-
sult from adaptative changes in brain neurochemistry
during development in response to the decreased ex-
pression levels of VAChT. If the deficits in social recog-
nition are related to decreased acetylcholine output,
acute inhibition of cholinesterase, which preserves
ACh in the synapse, might rescue the phenotype. There-
fore, we retested mice in the social memory task using
a paradigm that allowed us to treat mice with a cholines-
terase inhibitor prior to the experiment. The social rec-
ognition memory lasted at least 30 min, as wild-type
mice exposed to an intruder for 5 min twice, with an
intertrial interval of 30 min, explored the intruder signifi-
cantly less in the second exposure [F(5,70) = 17.21, p <
0.001] (Figure 6F). In contrast, there was no difference
for VAChT KDHET mice between the first and second
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We repeated these experiments after injecting mice with
either saline or galantamine (Figure 6F). The dose of gal-
antamine used (s.c., 1 mg/kg) has been shown to be
effective in improving cholinergic function in mice (Cser-
nansky et al., 2005), and it was sufficient to improve the
performance of VAChT KDHET in this social recognition
task (Figure 6F). Injection of saline had no effect on the
performance of wild-type or VAChT KDHET mice, ruling
out that prior manipulation of mice affected the outcome
of these experiments (data not shown). In addition, gal-
antamine did not alter the response of wild-type mice
(data not shown). It should be noted that the deficit in
social recognition memory was also observed in a small
number of VAChT KDHOM mice studied with an identical
protocol (Figure S2), thus confirming this phenotype for
the two mutant genotypes. Hence, it appears that
VAChT KDHET mice have a deficit in social memory due
to decreased cholinergic tone.
Discussion
To define the role of VAChT and ACh in physiological
functions and behavior, we generated a mouse line
with reduced expression of this transporter. The partial
decrease in VAChT expression is essential in these in-
vestigations as complete lack of the vesicular trans-
porter is likely to be incompatible with life, as shown
for other presynaptic cholinergic genes (Brandon et al.,
2004; Ferguson et al., 2004; Misgeld et al., 2002). Thus,
this reduced expression mouse line allowed us to exam-
ine the consequences of reduced cholinergic tone in
function, behavior, and cholinergic neurochemistry.
It has been demonstrated that several putative mRNA
species exist for VAChT, although V1 is predominant in
cholinergic tissues (Bejanin et al., 1994). In the present
experiments, we show that VAChT KDHET and KDHOM
mice have reduced levels of this major VAChT mRNA,
whereas an increase in a less common mRNA for VAChT
was detected, suggesting the existence of a compensa-
tory mechanism in mutant mice. The open reading frame
of VAChT is within the first intron of the ChAT gene. Inter-
estingly, we detected no changes in ChAT mRNA levels
in all CNS regions investigated, even though ChAT and
VAChT transcripts might be, under certain conditions,
coregulated (Eiden, 1998). In vertebrates, regulation of
the cholinergic gene locus expression is complex;
ChAT- and VAChT-specific mRNAs can be produced ei-
ther from different promoters or by alternative RNA
splicing (Oda, 1999).
In addition to the decrease in VAChT transcript, we
detected a 45% reduction in VAChT protein levels in
several CNS regions in VAChT KDHET mice, whereas
the reduction of VAChT protein levels in homozygous
mutant mice was 65%–70% of that found in wild-type lit-
termates. Therefore, the data indicate that protein levels
of VAChT closely follow the reduction of the major
VAChT mRNA species.
To evaluate how a decrease in VAChT levels affects
transmitter release, we examined quantal secretion of
ACh at the neuromuscular junction. Surprisingly, we ob-
served relatively mild alterations in the distribution of
quantal sizes in VAChT KDHET mice. A robust change
in quantal size distribution for VAChT KDHOM mice wasdetected; however, a very pronounced decrease in the
frequency of MEPPs was also observed. This decrease
in MEPP frequency is not the result of alterations in the
readily releasable pool of vesicles. It also seems unlikely
that the alteration in MEPP frequency is the result of de-
creased exocytosis, endocytosis, and total pool of ves-
icles, as FM1-43 experiments have shown no difference
in these parameters between wild-type and VAChT
KDHOM mice. We hypothesized that, if in synapses, the
number of copies of VAChT per synaptic vesicles is
low (Parsons et al., 1993; Van der Kloot, 2003), a reduc-
tion in VAChT abundance could result in electrophysio-
logically ‘‘silent’’ vesicles, and thus a decrease in MEPP
frequency. Prior experiments have demonstrated that
overexpression of VAChT in immature Xenopus spinal
neurons increases not only the amplitude but also the
frequency of miniature excitatory postsynaptic currents
(Song et al., 1997), indicating that, at least under certain
conditions, VAChT expression levels can affect electro-
physiological detection of exocytosis. Similarly, in Dro-
sophila mutants with decreased neuromuscular expres-
sion of the vesicular glutamate transporter, there are
major deficits in frequency of miniature end-plate cur-
rents, but no alterations in quantal size (Daniels et al.,
2006). Remarkably, VAChT phosphorylation by PKC af-
fects its trafficking to secretory vesicles, suggesting
that alterations in VAChT expression in synaptic vesicles
could occur physiologically (Krantz et al., 2000).
The results herein with VAChT mutant mice also indi-
cate that synaptic vesicle exocytosis is not altered by
decreased levels of the transporter; in this regard, these
results agree with similar observations in VMAT2-defi-
cient mice (Croft et al., 2005), which also present no
deficits in monoaminergic vesicle exocytosis. Nonethe-
less, the data show that VAChT KDHET mice have mild
changes in ACh release at the neuromuscular junction,
whereas VAChT KDHOM mice have a more profound
deficit in transmitter release.
Analysis of neuromuscular function in the three geno-
types corroborated these electrophysiological data.
VAChT KDHET mice performed as well as wild-type
mice in tests of motor function, whereas VAChT KDHOM
mice were significantly impaired in grip strength and
ability to hold their weight. Importantly, the deficit in
grip strength could be ameliorated by prior treatment
of mutant mice with cholinesterase inhibitors. The effect
of pyridostigmine, which is used to treat myasthenia,
is of particular importance, as it indicates that a periph-
eral cholinergic deficit due to alteration in neuromuscular
transmission is the cause of neuromuscular dysfunction.
Investigation of VAChT KD mice on the rotarod, a task
that depends upon motor learning and physical endur-
ance, reveals that VAChT KDHET are slower to learn
this motor task than wild-type control mice, but the for-
mer are able to reach the same level of performance in
time. In contrast, VAChT KDHOM mice are significantly
impaired and never improve their performance. That
VAChT KDHOM mice have limited capacity for exercise
is clearly observed on the treadmill, indicating that per-
formance of the homozygous mutants on the rotarod
also reflects their inability to maintain prolonged physi-
cal activity. These results suggest that VAChT KDHOM
mice may provide a model for study of the effects of
markedly reduced ACh release on neuromuscular
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congenital presynaptic myasthenia (Ohno et al., 2001).
In contrast, we were unable to detect any alteration in
neuromuscular function in VAChT KDHET mice. Release
of ACh accompanied the reduction of protein expres-
sion in the brain for VAChT KDHET mice, and both basal
and stimulated extracellular levels were affected. This
decrease in ACh release appears to be related to the
reduction of VAChT expression, as ChAT activity was
not decreased in these mutants. Overall, the approxi-
mately 45% reduction in VAChT expression appears to
decrease ACh secretion to a similar extent in the brain.
Unexpectedly, tissue ACh was significantly increased
in several brain regions from VAChT KDHET and VAChT
KDHOM mice, indicating a previously unrecognized con-
nection between ACh storage, nonvesicular ACh pools,
and tissue content. Molecular mechanisms responsible
for this increased tissue ACh content have not been un-
covered yet, but it does not seem to be due to altered
ChAT activity or high-affinity choline uptake. It is inter-
esting that pharmacological experiments with vesami-
col, an inhibitor of VAChT, have revealed a similar rela-
tionship, whereby decreased secretion of ACh leads to
accumulation of intracellular transmitter during nerve
stimulation (Collier et al., 1986).
Whereas VAChT KDHET mice present only mild defects
in neuromuscular neurotransmission, there is a relatively
larger deficiency in central ACh release in vivo. Neuro-
muscular transmission has a high safety margin, and
neuromuscular weakness is not observed until a signifi-
cant proportion of neuromotor units are compromised
(Paton and Waud, 1967; Waud and Waud, 1975). There-
fore, it is reasonable to envision that a partial decrease
in VAChT expression will cause more profound conse-
quences on cholinergic transmission in the brain, where
a relatively small number of synaptic vesicles (100–200
vesicles) need to be constantly recycled and refilled
with neurotransmitter. In contrast, at neuromuscular
synapses, there is a very large population of vesicles;
fast refilling of vesicles may not be as crucial for neuro-
transmission at the neuromuscular junction as it is for
brain synapses, at least when under low neuromuscular
demand.
The VAChT KDHET mice present a unique opportunity
to investigate the consequences of homogeneous de-
crease of ACh tone in cognitive tasks, as the results
show that these mice represent a model of moderate,
predominantly central cholinergic dysfunction. We ob-
served no deficits in performance of VAChT KDHET
mice in the step-down inhibitory avoidance test. A num-
ber of experiments have demonstrated that inhibition of
nicotinic and muscarinic central receptor activity can af-
fect performance of rats in this paradigm (Barros et al.,
2002), indicating an important cholinergic contribution
toward performance in this test. It is likely that the reduc-
tion of cholinergic function in VAChT KDHET mice was
below the threshold for detecting a learning or memory
impairment for this task. This result supports the notion
that ACh participates in, but is not essential for, some
hippocampal-dependent paradigms of learning and
memory (Parent and Baxter, 2004).
Interestingly, VAChT KDHET mice performed worse
than wild-type mice in an object recognition test, sug-
gesting that even mild decline of cholinergic functioncan affect cognitive processes required for this task. In-
deed, rats treated with 192 IgG-saporin, which leads to
cholinergic degeneration in the basal forebrain, also
present object recognition deficits (Paban et al., 2005),
and object recognition alterations are observed in cer-
tain mouse models of AD (Dewachter et al., 2002). It is
likely that VAChT KDHET present such deficits because
they have impairments in their ability to learn or remem-
ber the intricate cues necessary for discriminating the
novel object.
Our data also revealed an important role of cholinergic
tone in recognition of mouse conspecifics. In these
experiments, the KDHET mice explore unfamiliar mice;
however, their preference for a social stimuli is some-
what decreased compared with wild-type mice. None-
theless, the mutant mice are not socially deficient,
but they are clearly impaired in remembering intruder
mice when compared with wild-type mice. Absence of
deficits in olfactory discrimination in VAChT KDHET
mice supports the notion that the decreased social
memory is due to cognitive impairments rather than
a simple incapacity to process olfactory cues. An impor-
tant role of cholinergic tone in social recognition is sup-
ported by reversal of this phenotype in mice treated with
a cholinesterase inhibitor and by the fact that VAChT
KDHOM mice also present a significant deficit in social
recognition.
Social memory in rodents depends upon the activity
of vasopressin on V1A receptors in the lateral septum
(Bielsky et al., 2005) and upon the activity of oxytocin
(Bielsky and Young, 2004; Ferguson et al., 2000; Win-
slow and Insel, 2004). However, central muscarinic and
a7 nicotinic receptors have also been suggested to
play a role in social memory (Prediger et al., 2006; van
Kampen et al., 2004; Winslow and Camacho, 1995), indi-
cating a potential mechanism for ameliorating social
memory deficits in response to cholinergic decline.
Our observations support the notion that reduced cho-
linergic tone in AD mouse models can indeed cause
deficits in social memory. However, based on somewhat
similar impairments found in the object and social rec-
ognition tasks, it is possible that mild cholinergic deficits
may cause a more general memory deficit for recogniz-
ing previously learned complex cues, whether social or
not. Future detailed investigations will be necessary to
further define the specific type of cognitive processing
affected by cholinergic deficits in these mutants. Such
studies in mouse models of reduced cholinergic tone
may be particularly informative for understanding the
contribution of cholinergic decline to specific behavioral
alterations observed in certain pathologies of the CNS,
and may even be helpful in understanding physiological
aging (Cummings, 2004).
In conclusion, we have generated an animal model to
study the impact of decreased VAChT expression on
peripheral and central ACh neurotransmission and
function. The present results illuminate the role of VAChT
in vesicular ACh release and reveal that deficits in
VAChT-mediated filling of synaptic vesicles may have
important behavioral consequences. Furthermore, these
observations indicate an important role for ACh in cogni-
tive processes involved in object and social recognition
and memory. In this respect, a decrease in VAChT
expression is much less tolerated than a decrease in
Neuron
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evaluate cholinergic deficits in AD.
Experimental Procedures
Animal Care
Heterozygous mutant VAChT mice were backcrossed with C57BL/
6J animals for three generations; the N3 mice were used in most ex-
periments. Homozygous mutant VAChT mice were obtained by
intercrossing N3 heterozygous animals. Control animals were wild-
type age- and sex-matched littermates, and all behavioral and
most of the biochemical studies were conducted with researchers
‘‘blind’’ to the genotypes of the mice. For all behavioral experiments,
male mice were used.
Animals were housed in groups of three to five animals per cage in
a temperature-controlled room with a 12:12 light-dark cycles, and
food and water were provided ad libitum. All studies were con-
ducted in accordance with NIH guidelines for the care and use of
animals and with approved animal protocols from the Institutional
Animal Care and Use Committees at the Federal University of Minas
Gerais in Brazil, Pontificia Universidade Catolica de Rio Grande do
Sul in Brazil, and Duke University in the United States.
Wire-Hang, Grip Force, Rotarod, and Treadmill Tests
The wire-hang experiments were conducted as described (Sango
et al., 1996) and time spent hanging upside down was determined
with a cutoff time of 60 s.
To measure grip force, we used a custom-built force transducer
connected to a small support that could be grasped by the mouse
as described (Fowler et al., 2002). Five tests were performed per
mouse with a maximum period of 50 s for each animal over 2 differ-
ent days. The force transducer was coupled to a computer and a
routine was developed to record the maximal grip force exerted.
For the rotarod task, we followed the protocol described by Bran-
don et al. (1998). Mice were placed on the rotarod apparatus (Insight
Equipments, Ribeira˜o Preto, Brazil) and rotation was increased from
5 to 35 rpm. Latency to fall was recorded automatically. The test was
run within the last 4 hr of the light phase of the 12:12 cycle. Ten trials
were given on the first day and four trials on the second day, with
a 10 min intertrial interval. In the time between trials, mice were
placed in their home cage.
For the treadmill test (Insight Equipments, Ribeira˜o Preto, Brazil),
mice were trained for 4 days (3 min a day). On the first day, inclination
was set to 5. The inclination was increased by 5 for each training
day until reaching 20. The initial training speed was 8 m/min, and
the treadmill was accelerated by 1 m/min. In the second training ses-
sion, the initial speed was 10 m/min increased to 11 and 12 m/min
in the third and fourth training days, respectively. During testing,
the initial speed was set to 12 m/min, which was increased by
1 m/min at 2, 5, 10, 20, 30, 40, 50, and 60 min after starting the exer-
cise, essentially as described by Pederson et al. (2005). The work
performed (in J) was calculated with the following formula: W(J) =
body weight (kg) 3 cos 20 3 9.8 (J/kg 3 m) 3 distance (m).
Step-Down Inhibitory Avoidance
The step-down inhibitory avoidance apparatus was a 50 3 25 3
25 cm acrylic box which had a floor consisting of a grid of parallel
stainless steel bars 1 mm in diameter spaced 1 cm apart. A 10 cm2
wide, 2 cm high acrylic platform was placed in the center of the floor.
Animals were placed on the platform and their latency to step down
on the grid with all four paws was measured with an automatic
device. In the training session, immediately after stepping down
on the grid, the animals received a 2.0 s, 0.3 mA scrambled foot-
shock. Retention test sessions were procedurally identical, except
that no foot-shock was given. The latency to step down during test-
ing was taken as a measure of retention. A ceiling of 180 s was
imposed in this measure, i.e., animals whose test latency was over
than 180 s were counted as 180 s. Each animal was tested twice,
once at 1.5 hr after training, to measure short-term retention, and
once at 24 hr after training, to measure long-term retention (Iz-
quierdo et al., 2002; Lorenzini et al., 1996). Since the variable being
analyzed (step-down latency) does not follow a normal distribution,
the data were analyzed by Mann-Whitney U or Kruskal-Wallis non-parametric tests, followed by Dunn’s post hoc comparisons where
appropriated.
Object Recognition
All animals were given a single 5 min habituation session with no ob-
jects in the open-field arena (as described above). Twenty-four
hours after habituation, training was conducted by placing individual
mice for 5 min into the field, in which two identical objects (objects
A1 and A2; Duplo Lego toys) were positioned in two adjacent cor-
ners, 10 cm from the walls. A minimum of 30 s exploration time for
objects was allowed in this first exposure. In a short-term memory
(STM) test given 1.5 hr after training, the mice explored the open field
for 5 min in the presence of one familiar (A) and one novel (B) object.
All objects presented similar textures, colors, and sizes, but distinc-
tive shapes. A recognition index calculated for each animal was ex-
pressed by the ratio TB/(TA + TB) [TA = time spent exploring the famil-
iar object A; TB = time spent exploring the novel object B]. Between
trials the objects were washed with 10% ethanol solution and air-
dried. In a long-term memory (LTM) test given 24 hr after training,
the same mice explored the field for 5 min in the presence of familiar
object A and a novel object C. Recognition memory was evaluated
as for the short-term memory test. Exploration was defined as sniff-
ing or touching the object with nose and/or forepaws (de Lima et al.,
2005). Data for recognition indexes are expressed as median (inter-
quartile ranges). Comparisons among groups were performed using
a Kruskal-Wallis analysis of variance and Mann-Whitney U tests.
Recognition indexes within individual groups were analyzed with
Wilcoxon tests.
Social Recognition
Mice were housed in individual cages in a quiet room for 4 days to
establish territory dominance. Swiss juvenile male mice were used
as the intruder. To test for social interaction, the intruder was placed
inside a transparent acrylic chamber containing several holes and
introduced into the test cage exactly as described (Choleris et al.,
2003). Time spent sniffing was measured as the amount of time
that VAChT KDHET mice or wild-type littermates spent poking their
noses into the holes of the chamber. Initially, the subject tested
(wild-type or VAChT KDHET mouse) was exposed to an empty acrylic
chamber for 10 min; subsequently, this chamber was exchanged by
one containing the intruder and left for 5 min. The entire procedure
was repeated four times. After the fourth exposure to the same
intruder, a novel intruder was added to the acrylic chamber. The ex-
periment was videotaped and a trained researcher, blind to geno-
type, evaluated time spent sniffing in each condition.
A second experiment consisted of exposing the subject to the
same intruder twice with an intertrial interval of 30 min. The standard
measure for the statistical analysis in social recognition tests was
the time spent exploring the juvenile intruder. To evaluate the contri-
bution of acute cholinergic deficits, saline or 1 mg/kg galantamine
(s.c.) was injected 30 min before beginning of the tests.
For evaluation of sociability, we followed the protocol described
by Kwon et al. (2006). Testing was done in a three-chambered appa-
ratus (153 903 18.5 cm divided into three chambers of 153 29 cm
and separated by dividers with a central 3.8 3 3.8 cm door) that of-
fers the subject a choice between a social stimulus and an inanimate
target. In the habituation session, mice were allowed to explore the
entire box for 10 min. Subsequently, mice stayed 5 min in the center
and were then allowed to interact for 10 min with an empty cage in
one chamber versus a caged social target in the opposite chamber.
Social and nonsocial stimuli were varied among the chambers and
the box was cleaned between tests. Results are presented as per-
centage of total exploration time.
Two tests to evaluate the olfactory responses of the mice were
conducted (Bielsky et al., 2005; Ferguson et al., 2000). The first con-
sisted of measuring the time that both genotypes took to find a candy
located on the surface of bedding or hidden within the bedding (Fer-
guson et al., 2000). The second test investigated whether VAChT
KDHET mice presented olfactory habituation and discrimination. Ex-
periments were performed 7 days after completing the social recog-
nition tests in the same groups of mice. For this test, a microtube,
with a piece of cotton containing 10 ml of strawberry essence, was
presented to mice four times for 1 min with a 10 min intertrial interval.
On the fifth trial, the microtube was exchanged with one containing
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was determined by Student’s t test or two-way ANOVA, and a post
hoc Bonferroni test was performed when appropriate. Changes
across trials were assessed with repeated measures ANOVA with
Bonferroni’s post hoc analysis.
For all other methods, see the Supplemental Data.
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/51/5/601/DC1/.
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